Stuart Brown

Stuart Brown

Auto-generated profile, based on publicly available information

Stuart Brown

NYU Center for Health Informatics and Bioinformatics, New York University School of Medicine, New York, NY 10016, USA

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2019 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
IGIan Ganly
Ian Ganly
LYLiying Yang
Liying Yang
RGRachel A. Giese
Rachel A. Giese
YHYuhan Hao
Yuhan Hao
CNCarlos W. Nossa
Carlos W. Nossa
ZPZhiheng Pei
Zhiheng Pei
Over the past decade, there has been a change in the epidemiology of oral cavity squamous cell cancer (OC‐SCC). Many new cases of OC‐SCC lack the recognized risk factors of smoking, alcohol and human papilloma virus. The aim of this study was to determine if the oral microbiome may be associated with OC‐SCC in nonsmoking HPV negative patients. We compared the oral microbiome of HPV‐negative nonsmoker OC‐SCC(n = 18), premalignant lesions(PML) (n = 8) and normal control patients (n = 12). Their oral microbiome was sampled by oral wash and defined by 16S rRNA gene sequencing. We report that the periodontal pathogens Fusobacterium, Prevotella, Alloprevotella were enriched while commensal Streptococcus depleted in OC‐SCC. Based on the four genera plus a marker genus Veillonella for PML, we classified the oral microbiome into two types. Gene/pathway analysis revealed a progressive increase of genes encoding HSP90 and ligands for TLRs 1, 2 and 4 along the controls→PML → OC‐SCC progression sequence. Our findings suggest an association between periodontal pathogens and OC‐SCC in non smoking HPV negative patients.

16 March 2007 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
ABAlyssa E Barry
Alyssa E Barry
ALAleksandra Leliwa-Sytek
Aleksandra Leliwa-Sytek
LTLivingston Tavul
Livingston Tavul
HIHeather Imrie
Heather Imrie
FMFlorence Migot-Nabias
Florence Migot-Nabias
KDKaren P Day
Karen P Day
Var genes encode the major surface antigen (PfEMP1) of the blood stages of the human malaria parasite Plasmodium falciparum. Differential expression of up to 60 diverse var genes in each parasite genome underlies immune evasion. We compared the diversity of the DBLα domain of var genes sampled from 30 parasite isolates from a malaria endemic area of Papua New Guinea (PNG) and 59 from widespread geographic origins (global). Overall, we obtained over 8,000 quality-controlled DBLα sequences. Within our sampling frame, the global population had a total of 895 distinct DBLα “types” and negligible overlap among repertoires. This indicated that var gene diversity on a global scale is so immense that many genomes would need to be sequenced to capture its true extent. In contrast, we found a much lower diversity in PNG of 185 DBLα types, with an average of approximately 7% overlap among repertoires. While we identify marked geographic structuring, nearly 40% of types identified in PNG were also found in samples from different countries showing a cosmopolitan distribution for much of the diversity. We also present evidence to suggest that recombination plays a key role in maintaining the unprecedented levels of polymorphism found in these immune evasion genes. This population genomic framework provides a cost effective molecular epidemiological tool to rapidly explore the geographic diversity of var genes. Malaria parasites live in red blood cells of the human host for part of the life cycle, during which a family of diverse antigens known as PfEMP1 are placed on the surface. PfEMP1 variants switch by sequential expression of up to 60 var genes. This allows the parasite to evade immune detection within an individual host, enhancing its chances to be transmitted to the mosquito vector in situations where mosquitoes are seasonally available. Methods to rapidly assess var gene diversity in parasite populations are needed to measure antigenic diversity and define relationships with malaria transmission. Using a specialized framework, we completed the first systematic sampling of var genes from parasite genomes obtained from the same (Papua New Guinea [PNG]) and different (global) populations. Globally, there was no limit to the number of var genes because parasites rarely shared var genes. In PNG, var gene numbers were restricted due to high levels of sharing, and most were only found in that population. Recombination was important to the evolution of var genes in PNG. The data suggest there are distinct var genes in different populations, which may have consequences for the spread of malarial disease from one geographic area to another.

17 July 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GTGeorge Tetz
George Tetz
SBStuart M. Brown
Stuart M. Brown
YHYuhan Hao
Yuhan Hao
VTVictor Tetz
Victor Tetz
Recent studies suggest that alterations in the gut phagobiota may contribute to pathophysiological processes in mammals; however, the association of bacteriophage community structure with Parkinson’s disease (PD) has not been yet characterized. Towards this end, we used a published dataset to analyse bacteriophage composition and determine the phage/bacteria ratio in faecal samples from drug-naive PD patients and healthy participants. Our analyses revealed significant alterations in the representation of certain bacteriophages in the phagobiota of PD patients. We identified shifts of the phage/bacteria ratio in lactic acid bacteria known to produce dopamine and regulate intestinal permeability, which are major factors implicated in PD pathogenesis. Furthermore, we observed the depletion of Lactococcus spp. in the PD group, which was most likely due to the increase of lytic c2-like and 936-like lactococcal phages frequently present in dairy products. Our findings add bacteriophages to the list of possible factors associated with the development of PD, suggesting that gut phagobiota composition may serve as a diagnostic tool as well as a target for therapeutic intervention, which should be confirmed in further studies. Our results open a discussion on the role of environmental phages and phagobiota composition in health and disease.

1 July 2009 in DNA Repair
Verified
Journal Article
Closed access
MCMichael K. Chan
Michael K. Chan
MOMaria T. Ocampo-Hafalla
Maria T. Ocampo-Hafalla
VVVladimir Vartanian
Vladimir Vartanian
PJPawel Jaruga
Pawel Jaruga
GKGüldal Kirkali
Güldal Kirkali
GTGeorge W. Teebor
George W. Teebor

1 February 2018 in Cell
Verified
Journal Article
Closed access
HJHeekyung Jung
Heekyung Jung
MBMyungin Baek
Myungin Baek
KDKristen P. D’eLia
Kristen P. D’eLia
CBCatherine Boisvert
Catherine Boisvert
PCPeter D. Currie
Peter D. Currie
JDJeremy S. Dasen
Jeremy S. Dasen

23 March 2014 in Nature Methods
Verified
Journal Article
Open access
PDF file
MMMatthew Murtha
Matthew Murtha
ZKZeynep Tokcaer Keskin
Zeynep Tokcaer Keskin
ZTZuojian Tang
Zuojian Tang
FSFrancesco Strino
Francesco Strino
XCXi Chen
Xi Chen
LDLisa Dailey
Lisa Dailey
Promoters and enhancers establish precise gene transcription patterns. The development of functional approaches for their identification in mammalian cells has been complicated by the size of these genomes. Here we report a high-throughput functional assay for directly identifying active promoter and enhancer elements called FIREWACh (Functional Identification of Regulatory Elements Within Accessible Chromatin), which we used to simultaneously assess over 80,000 DNA fragments derived from nucleosome-free regions within the chromatin of embryonic stem cells (ESCs) and identify 6,364 active regulatory elements. Many of these represent newly discovered ESC-specific enhancers, showing enriched binding-site motifs for ESC-specific transcription factors including SOX2, POU5F1 (OCT4) and KLF4. The application of FIREWACh to additional cultured cell types will facilitate functional annotation of the genome and expand our view of transcriptional network dynamics.